MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 61 filers reported holding MENLO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $219,000 | +271.2% | 125,890 | +478.1% | 0.00% | – |
| Q1 2020 | $59,000 | -19.2% | 21,775 | +37.9% | 0.00% | – |
| Q4 2019 | $73,000 | +108.6% | 15,787 | +100.1% | 0.00% | – |
| Q3 2019 | $35,000 | -43.5% | 7,889 | -23.7% | 0.00% | – |
| Q2 2019 | $62,000 | +129.6% | 10,335 | +212.3% | 0.00% | – |
| Q1 2019 | $27,000 | +2600.0% | 3,309 | +1086.0% | 0.00% | – |
| Q4 2018 | $1,000 | -97.3% | 279 | -92.7% | 0.00% | – |
| Q3 2018 | $37,000 | +640.0% | 3,843 | +495.8% | 0.00% | – |
| Q2 2018 | $5,000 | -90.0% | 645 | -51.5% | 0.00% | – |
| Q1 2018 | $50,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,461,552 | $11,473,000 | 9.29% |
| Vivo Capital, LLC | 4,011,236 | $31,488,000 | 3.14% |
| DAFNA Capital Management LLC | 600,030 | $4,710,000 | 2.03% |
| GREAT POINT PARTNERS LLC | 2,057,027 | $16,148,000 | 1.60% |
| MANGROVE PARTNERS IM, LLC | 561,138 | $4,405,000 | 0.59% |
| Alambic Investment Management, L.P. | 66,996 | $526,000 | 0.22% |
| FIRST MANHATTAN CO. LLC. | 2,256,903 | $17,716,000 | 0.10% |
| Orbimed Advisors | 633,920 | $4,976,000 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 198,451 | $1,558,000 | 0.06% |
| Baker Brothers Advisors | 700,000 | $5,495,000 | 0.04% |